Explore All Access
Check if your research matches the topics covered in JOURNAL OF HEPATOCELLULAR CARCINOMA?
- Degree of match
- Common matching concepts
- Additional journal recommendations
JOURNAL OF HEPATOCELLULAR CARCINOMA : Impact Factor & More
eISSN: 2253-5969pISSN: 2253-5969
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
JOURNAL OF HEPATOCELLULAR CARCINOMA Key Metrics
Eigenfactor 
< 0.001
Impact Factor
< 5
Topics Covered on JOURNAL OF HEPATOCELLULAR CARCINOMA
Immunotherapy
Hepatocellular carcinoma
Hepatitis B virus
Overall survival
Progression-free survival
Nanogel
Computed tomography
Lactate dehydrogenase
Chronic hepatitis
Radiofrequency ablation
Sorafenib
Proton therapy
Photon radiation
Cirrhosis
Tumor tissue
Hepatitis C virus
Combination immunotherapy
Bevacizumab
Cabozantinib
Surgical resection
JOURNAL OF HEPATOCELLULAR CARCINOMA Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ 
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in JOURNAL OF HEPATOCELLULAR CARCINOMA ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in JOURNAL OF HEPATOCELLULAR CARCINOMA
Oxymatrine Inhibits PD-L1 by Downregulating IFN-γ to Promote Ferroptosis and Enhance Anti-PD-L1 Efficacy in Liver Cancer.
- 1 Dec 2024
- Journal of hepatocellular carcinoma
Long-Term Outcomes of Laparoscopic Anatomical versus Non-Anatomical Liver Resection for Hepatocellular Carcinoma.
- 1 Dec 2024
- Journal of hepatocellular carcinoma
M6A-Methylated NUTM2B-AS1 Promotes Hepatocellular Carcinoma Stemness Feature via Epigenetically Activating BMPR1A Transcription.
- 1 Dec 2024
- Journal of hepatocellular carcinoma
Deep Learning-Based Automatic Segmentation Combined with Radiomics to Predict Post-TACE Liver Failure in HCC Patients
- 1 Dec 2024
- Journal of Hepatocellular Carcinoma
Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC.
- 1 Dec 2024
- Journal of hepatocellular carcinoma
PPIH Expression Correlates with Tumor Aggressiveness and Immune Dysregulation in Hepatocellular Carcinoma.
- 1 Dec 2024
- Journal of hepatocellular carcinoma
Oxymatrine Inhibits PD-L1 by Downregulating IFN-γ to Promote Ferroptosis and Enhance Anti-PD-L1 Efficacy in Liver Cancer.
- 1 Dec 2024
- Journal of hepatocellular carcinoma
Long-Term Outcomes of Laparoscopic Anatomical versus Non-Anatomical Liver Resection for Hepatocellular Carcinoma.
- 1 Dec 2024
- Journal of hepatocellular carcinoma
M6A-Methylated NUTM2B-AS1 Promotes Hepatocellular Carcinoma Stemness Feature via Epigenetically Activating BMPR1A Transcription.
- 1 Dec 2024
- Journal of hepatocellular carcinoma
Deep Learning-Based Automatic Segmentation Combined with Radiomics to Predict Post-TACE Liver Failure in HCC Patients
- 1 Dec 2024
- Journal of Hepatocellular Carcinoma
Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC.
- 1 Dec 2024
- Journal of hepatocellular carcinoma
PPIH Expression Correlates with Tumor Aggressiveness and Immune Dysregulation in Hepatocellular Carcinoma.
- 1 Dec 2024
- Journal of hepatocellular carcinoma
Compare Similar Journals with JOURNAL OF HEPATOCELLULAR CARCINOMA
Select Journals to Compare with JOURNAL OF HEPATOCELLULAR CARCINOMA
Total journals - 10
You can select up to 3 Journals at a time
Journal of Hepatology
Publisher: ELSEVIER
Liver International
Publisher: WILEY
Hepatology Research
Publisher: WILEY
Frontiers in Oncology
Publisher: FRONTIERS MEDIA SA
Cancers
Publisher: MDPI
Hepatology International
Publisher: SPRINGER
Hepatology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Liver Cancer
Publisher: KARGER
World Journal of Gastroenterology
Publisher: BAISHIDENG PUBLISHING GROUP INC
Digestive and Liver Disease
Publisher: ELSEVIER SCIENCE INC
0 Journals Selected to compare with
JOURNAL OF HEPATOCELLULAR CARCINOMA
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on JOURNAL OF HEPATOCELLULAR CARCINOMA
How long has JOURNAL OF HEPATOCELLULAR CARCINOMA been actively publishing? 
JOURNAL OF HEPATOCELLULAR CARCINOMA has been in operation since 2014 till date.
What is the publishing frequency of JOURNAL OF HEPATOCELLULAR CARCINOMA?
JOURNAL OF HEPATOCELLULAR CARCINOMA published with a Continuous publication frequency.
How many articles did JOURNAL OF HEPATOCELLULAR CARCINOMA publish last year?
In 2023, JOURNAL OF HEPATOCELLULAR CARCINOMA publsihed 175 articles.
What is the eISSN & pISSN for JOURNAL OF HEPATOCELLULAR CARCINOMA?
For JOURNAL OF HEPATOCELLULAR CARCINOMA, eISSN is 2253-5969 and pISSN is 2253-5969.
Who is the publisher of JOURNAL OF HEPATOCELLULAR CARCINOMA?
DOVE MEDICAL PRESS LTD is the publisher of JOURNAL OF HEPATOCELLULAR CARCINOMA.
